⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JBIO News
Jade Biosciences, Inc. Common Stock
Form 8-K
sec.gov
JBIO
Form 8-K
sec.gov
JBIO
Jade Biosciences Announces Appointment of Mark Eisner, M.D., M.P.H., to Board of Directors
globenewswire.com
JBIO
Form 8-K
sec.gov
JBIO
Jade Biosciences Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
globenewswire.com
JBIO
Form 8-K
sec.gov
JBIO
Jade Biosciences Announces Pricing of Public Offering of Common Stock
globenewswire.com
JBIO
Jade Biosciences Announces Proposed Underwritten Public Offering
globenewswire.com
JBIO
Form 8-K
sec.gov
JBIO
Jade Biosciences Announces Positive Interim Phase 1 Results for JADE101 Demonstrating Potential Best-in-Class Profile and Every-12-Week Dosing in IgA Nephropathy
globenewswire.com
JBIO